| Inbound Relationships | 
Type | 
Active | 
Source | 
Characteristic | 
Refinability | 
Group | 
| Ondansetron (Alphapharm) 8 mg/4 mL injection, 5 x 4 mL ampoules | 
has TP | 
True | 
Ondansetron (Alphapharm) | 
Inferred relationship | 
Some | 
  | 
| Ondansetron (Alphapharm) 4 mg/2 mL injection, 2 mL ampoule | 
has TP | 
True | 
Ondansetron (Alphapharm) | 
Inferred relationship | 
Some | 
  | 
| Ondansetron (Alphapharm) 4 mg/2 mL injection, 2 mL ampoule | 
Is a | 
True | 
Ondansetron (Alphapharm) | 
Inferred relationship | 
Some | 
  | 
| Ondansetron (Alphapharm) 4 mg/2 mL injection, 5 x 2 mL ampoules | 
has TP | 
True | 
Ondansetron (Alphapharm) | 
Inferred relationship | 
Some | 
  | 
| Ondansetron (Alphapharm) 8 mg/4 mL injection, 4 mL ampoule | 
Is a | 
True | 
Ondansetron (Alphapharm) | 
Inferred relationship | 
Some | 
  | 
| Ondansetron (Alphapharm) 8 mg/4 mL injection, 5 x 4 mL ampoules | 
has TP | 
True | 
Ondansetron (Alphapharm) | 
Inferred relationship | 
Some | 
  | 
| Ondansetron (Alphapharm) 4 mg/2 mL injection, 2 mL ampoule | 
has TP | 
True | 
Ondansetron (Alphapharm) | 
Inferred relationship | 
Some | 
  | 
| Ondansetron (Alphapharm) 8 mg/4 mL injection, 4 mL ampoule | 
has TP | 
True | 
Ondansetron (Alphapharm) | 
Inferred relationship | 
Some | 
  | 
| Ondansetron (Alphapharm) 8 mg/4 mL injection, 4 mL ampoule | 
has TP | 
True | 
Ondansetron (Alphapharm) | 
Inferred relationship | 
Some | 
  | 
| Ondansetron (Alphapharm) 4 mg/2 mL injection, 5 x 2 mL ampoules | 
has TP | 
True | 
Ondansetron (Alphapharm) | 
Inferred relationship | 
Some | 
  |